Revolutionary 'Smart' Drug Delivery: A New Era in Glioblastoma and Skin Disease Treatments
Researchers at the University of Sheffield are pioneering a novel method to deliver chemotherapy directly to tumor sites and treat severe skin diseases. The project, using Cold Atmospheric Plasma and Molecularly Imprinted Polymers, promises precision treatments and improved drug efficacy for glioblastoma, autoimmune diseases, and fungal infections.
- Country:
- United Kingdom
The University of Sheffield's groundbreaking research introduces a transformative approach to chemotherapy delivery and skin disease treatment. This £1 million project, funded by the EPSRC, explores the integration of Cold Atmospheric Plasma (CAP) and Molecularly Imprinted Polymers (MIPs) for precision medicine.
Led by Professors Rob Short and Nick Turner, the initiative focuses on delivering targeted treatments for glioblastoma, autoimmune conditions, and invasive fungal infections. The innovative method uses molecular imprinting to enclose drugs within a custom-fitted hydrogel, enabling efficient localized treatment.
Highlighting a significant shift in medical care, this technology leverages AI modeling to enhance delivery efficacy. With a dual-action benefit of oxygenating tissues and accelerating healing, this system holds promise for expansive medical applications and strengthening the concept of patient-specific therapies.
Google News